16.06.2008 12:00:00

CIGNA HealthCare Selects GI Pathology, PLLC as a National Gastrointestinal Pathology Provider

GI Pathology, PLLC announced today that it has entered into a new, national agreement (Agreement) with CIGNA HealthCare ("CIGNA”), an affiliate of CIGNA Corporation (NYSE: CI), effective June 15, 2008. Under the terms of the Agreement, GI Pathology, PLLC will become a participating gastrointestinal pathology laboratory for CIGNA. "We are very pleased to have been selected by CIGNA as a national pathology provider within their laboratory network,” commented Patrick J. Dean, M.D., Chairman of GI Pathology, PLLC. "Our relationship with CIGNA is an important step towards delivering sub-specialized pathology nationwide.” "GI Pathology has a commitment to delivering the highest quality gastrointestinal pathology diagnoses to our GI clients,” Dean added. "Our agreement with CIGNA recognizes our commitment and the value of the benefits we deliver to CIGNA and its members.” About CIGNA HealthCare, Inc. CIGNA HealthCare, based in Bloomfield, CT, provides medical benefits plans, dental coverage, behavioral health coverage, pharmacy benefits and products and services that integrate and analyze information to support consumerism and health advocacy. "CIGNA HealthCare" refers to certain operations of Connecticut General Life Insurance Company, which is an operating subsidiary of CIGNA Corporation (NYSE:CI). Products and services are provided by such operating subsidiaries, and not by CIGNA Corporation. For more information, visit http://www.CIGNA.com. About GI Pathology, PLLC Founded in 1995, GI Pathology is the only physician-owned laboratory in the United States dedicated solely to the practice of gastrointestinal and liver pathology. The company provides the highest quality GI pathology diagnoses, made exclusively by one of its fellowship-trained gastrointestinal and liver pathologists. Centrally located in Memphis, Tennessee, the company guarantees that pathology results will be delivered back to its nationwide client base within an industry-leading 24 hours. For more information, visit the company website at http://www.gipath.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Cigna Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cigna Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 500 5 998,74 -0,38%
S&P 100 2 883,15 -0,41%